Filter
600
Text search:
JJ
Medicine
Featured
Recommendations
44
New Publications
87
Language
Document type
No document type
310
Studies & Reports
148
Guidelines
84
Manuals
31
Training Material
11
Strategic & Response Plan
8
Fact sheets
7
Videos
1
Countries / Regions
Global
31
India
20
Africa
18
Brazil
14
Latin America and the Carribbean
14
Russia
13
South Africa
11
Ethiopia
8
Uganda
8
Kenya
8
Malawi
8
Ukraine
7
Sierra Leone
6
Zimbabwe
6
Mozambique
6
Western and Central Europe
6
Cameroon
5
Philippines
5
Germany
5
Congo, Democratic Republic of
4
USA
4
Tanzania
4
Indonesia
4
Peru
4
Eastern Europe
4
North America
4
Burkina Faso
3
Haiti
3
Zambia
3
Rwanda
3
Colombia
3
Angola
3
West and Central Africa
3
Middle East and North Africa
3
Paraguay
3
Asia
3
Spain
3
Liberia
2
Nigeria
2
Guinea-Bissau
2
Nepal
2
Afghanistan
2
Bangladesh
2
Argentina
2
Eastern Europe and Central Asia
2
Venezuela
2
Guinea
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Pakistan
1
South Sudan
1
Syria
1
Thailand
1
Singapore
1
Papua New Guinea
1
Sudan
1
Benin
1
Eswatini/ Swaziland
1
Burundi
1
Ecuador
1
Botswana
1
El Salvador
1
Bolivia
1
Madagascar
1
Lesotho
1
Myanmar / Burma
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
South–East Asia Region
1
Western Pacific Region
1
Mongolia
1
Qatar
1
Moldova
1
Kyrgyzstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
146
Clinical Guidelines
64
Public Health
39
Women & Child Health
24
Capacity Building
5
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
Mental Health
103
COVID-19
68
HIV
47
TB
42
NCDs
38
Planetary Health
32
NTDs
32
Ebola
26
AMR
20
Disability
15
Pharmacy
10
Caregiver
9
Global Health Education
8
Rapid Response
7
Zika
7
Cholera
2
Refugee
2
Social Ethics
2
Polio
1
Natural Hazards
1
Specific Hazards
1
Health Financing Toolbox
1
BMJ Global Health2020;5:e001980. doi:10.1136/bmjgh-2019-00198
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h
...
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr
...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalizaçã
...
orientations provisoires, 14 juin 2021
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
MAMI refers to the management of small and nutritionally at risk infants under six months of age (infants u6m) and their mothers.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an
...
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con
...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti
...
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C
...